RECURSION PHARMACEUTICALS IN shareholders Q3 2023

RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 190 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.9%.

RECURSION PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
LPL Financial LLC 68,410$523,3370.00%
Citadel Advisors 78,700$602,0550.00%
Citadel Advisors 83,500$638,7750.00%
Citadel Advisors 303,090$2,318,6390.00%
Allworth Financial LP 50$3830.00%
Smithfield Trust Co 1,099$80.00%
Legal & General Group Plc 118,050$903,0830.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 221,600$1,695,2400.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 270,400$2,068,5600.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 307,833$2,354,9220.00%
D. E. Shaw & Co., Inc. 23,707$181,3590.00%
GTS SECURITIES LLC 10,476$80,1410.00%
ROYAL BANK OF CANADA 26,165$200,0000.00%
Creative Planning 18,287$139,8960.00%
COMMONWEALTH EQUITY SERVICES, LLC 21,185$1620.00%
TD Waterhouse Canada Inc. 100$7170.00%
Daiwa Securities Group Inc. 731$60.00%
Pictet Asset Management Holding SA 14,987$114,6510.00%
Covestor Ltd 16$00.00%
Western Pacific Wealth Management, LP 20$1530.00%
External links

This page lists RECURSION PHARMACEUTICALS IN's shareholders in Q3 2023. To view RECURSION PHARMACEUTICALS IN's shareholder history, click here.